Table 8 Comparison of EBD [DALYs] between pyrethroids (for ADHD) and lead (for CVD, IDID and kidney diseases). EBD results of lead are adapted from the IHME for the year 2021. EBD estimates are for the age category 0–19 years
Country | EBD pyrethroids (95% CI) [DALYs] | EBD lead (95% CI) [DALYs] | Ratio EBD pyrethroids to EBD lead |
|---|---|---|---|
France | 1393 (425–2455) | 1031 (257–2259) | 1.35 |
Iceland | 4 (1–9) | 2.93 (0.5–7) | 1.37 |
Switzerland | 103 (16–204) | 83 (14–198) | 1.24 |
Germany | 218 (-80–613) | 585 (68–1492) | 0.37 |
Israel | 258 (60–455) | 252 (63–527) | 1.02 |